Segregation of a PRKCG Mutation in Two RP11 Families  by Al-Maghtheh, Mai et al.
Am. J. Hum. Genet. 62:1248–1252, 1998
1248
Letters to the Editor
Am. J. Hum. Genet. 62:1248, 1998
Segregation of a PRKCG Mutation in
Two RP11 Families
To the Editor:
Retinitis pigmentosa (RP) is a group of inherited neu-
rodegenerative disorders of the retina. RP patients ex-
perience night blindness and tunnel vision (constricted
visual fields) at an early stage and may become com-
pletely blind in the advanced stages of the disease (Bird
1995). RP is both clinically and genetically heteroge-
neous. The autosomal dominant subgroup of RP (adRP)
can be caused by mutations in at least two genes, rho-
dopsin (3q21) and peripherin (6p12), and in seven other
loci mapped by linkage analysis (Xu et al. 1996). We
mapped the chromosome 19q locus (also known as
“RP11” [MIM 600138; http://www.ncbi.nlm.nih.gov/
htbin-post/Omim]; McKusick 1994) in four British fam-
ilies (Al-Maghtheh et al. 1996). A Japanese family (Xu
et al. 1995) and three American families (McGee et al.
1997) also had linkage to this locus, suggesting that
RP11 is a major locus for adRP (Al-Maghtheh et al.
1996). Interestingly, the phenotype in these families is
characterized by “bimodal expressivity”; symptomatic
RP patients have a relatively early onset of the disease,
whereas some obligate disease-gene carriers are indistin-
guishable from normal individuals. Recombination
events in the families with linkage have refined the lo-
calization of the RP11 gene to a 5-cM interval between
markers D19S572 and D19S418, in the telomeric region
of chromosome 19q13.4 (McGee et al. 1997). Among
the positional candidate genes and expressed sequence
tags mapping in this region is the gene PRKCG, a mem-
ber of the protein kinase C (PKC) gene family (Hug and
Sarre 1993).
PKC is a multifunctional family of closely related ser-
ine/threonine protein kinases. PKCs function in a wide
variety of cellular processes, such as membrane-receptor
signal transduction and control of gene expression. Var-
ious PKC isoenzymes are expressed in a tissue-specific
manner (Hug and Sarre 1993). The PKC gene family
has been shown to be expressed widely in the retina,
although it is not clear which isoenzymes are involved
in any particular retinal cell type (Newton and Williams
1993; Ohki et al. 1994). The observation by Newton
and Williams (1991; 1993) that PKC phosphorylates
rhodopsin in a light-dependent manner suggests the in-
volvement of these kinases in desensitization of the pho-
topigment. InDrosophila phototransduction, a PKC iso-
enzyme known as “eye-PKC” was found to be
exclusively expressed in photoreceptor cells (Schaeffer
et al. 1989). A mutation in eye-PKC has been shown to
be responsible for the recessive inaC (inactivation no
after potential C) Drosophila mutant, which exhibits
photoreceptor deactivation and retinal degeneration
(Smith et al. 1991). However, the specific-tissue expres-
sion and function of the PKCg isoenzyme in the human
retina is not yet clearly defined. Several reports have
shown PKCg to be expressed in rabbit, rat, frog, and
goldfish retinas (Osborne et al. 1992). This expression
of PKCg is confined to amacrine and ganglion cells. No
expression has been detected in the photoreceptors. This
does not exclude the possibility that PKCg expression
in photoreceptors is at levels below the sensitivity of the
detection method. Therefore, in addition to its being a
positional candidate, there is circumstantial evidence to
implicate PRKCG as a candidate for the RP11 gene. We
have recently characterized the genomic structure of the
PRKCG gene. The gene has 18 exons, and the intron-
exon boundaries, including splice-site consensus se-
quences, have been defined. Amplification primers for
each exon are listed in table1.
In this study, we screened the PRKCG gene for mu-
tations, in RP11 families. All 18 exons and the 1.5-kb
5′ UTR were screened by both heteroduplex analysis
(Keen et al. 1991) and direct genomic sequencing. We
identified a point mutation that segregates with RP in
two families, RP1907 (Al-Maghtheh et al. 1996) and
ADRP24 (denoted as “family 2” by Moore et al. 1993;
also see the legend to fig. 3). Another two isolated RP
patients with a family history indicating dominant dis-
ease were also found to have the same mutation. This
mutation was a CrA transversion, which substitutes a
serine for an arginine residue at codon 659 of the
PRKCG gene within the C4 catalytic domain (fig. 1).
This residue is conserved in all known PRKCG genes,
including human, bovine, and rat genes. The presence
and segregation of this mutation (the sequence of which
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Table 1
Primer Sequences (5′–3′) Used in Amplification of the 18 PRKCG Exons, and PCR
Conditions for each Amplification
Forward Primer Reverse Primer
[Mg],
Annealing Temperature
1F, agaaaggcaggatcctggtc 1R, cggcgtgataggagtctgca 1.5, 65C
2F, ttggacacctgggccctgc 2R, ctgagggtcccaggagcc 1.5, 65C
3F, gctggactaatccatgcctc 3R, aggagaaattgggacggacg 1.3, 60C
4F, gctgacctagagagcaaggc 4R, gctttggaagggccctggca 1.5, 65C
5F, tgaggtgctacccgcagctt 5R, acaagtgccttgggtcagcc 1.5, 64C
6F, ctctaacccgtcacactctt 6R, tctgtcagctgtcattgcct 1.5, 60C
7F, gccatgagctcggctctgca 7R, gtaatattgcgctccatcccc 1.5, 65C
8F, tgcctctcccatgggtgc 8R, aaggccagctctgaaccgt 1.5, 60C
9F, ctatctatcgccatggct 9R, aactgcctccattcaacg 1.5, 58C
10F, gagcatttccttatcggctg 10R, aaccagaaatctgaccttccc 1.3, 55C
11F, aggtcctgtaccactgggtt 11R, atcccaacgcagatgtccag 1.5, 65C
12F, gtagatggatcccgcctcta 12R, acgtcagaaggtcagtggct 1.0, 58C
13F, agccactgaccttctgacgt 13R, gtgttgagttcagcagtctag 1.5, 60C
14F, ctagactgctgaactcaacac 14R, taagggatctcaaagcgtg 1.5, 56C
15F, gcacttaacgtgggtagcg 15R, tagccaagccagcttctcc 1.5, 56C
16F, gcatgtccctgactctctat 16R, agtgacttcaggaatgggag 1.5, 60C
17F, atgtacctgtccggcact 17R, accaggtttttgttgcctgg 1.5, 55C
18F, ctcggagctgcttaactttcc 18R, acgttggggacacctagtgg 1.5, 64C
Figure 1 Diagrammatic representation of the position of the Arg659Ser mutation within exon 18 of (a) the DNA sequence and (b) the
domain structure of PKCg, as described by Hug and Sarre (1993). C1–C4 are the conserved domains, which are flanked and separated by the
variable domains, V1–V5. V1–C2 represents the regulatory domain, which is separated from the catalytic domain (C3–V5) by V3 or the hinge
region. C3 contains the ATP-binding site.
is shown in fig. 2) was also confirmed by digestion of
the PCR product of exon 18 by the restriction enzyme
AciI (fig. 3). This mutation was absent from 500 normal
control chromosomes. Haplotype analysis in these two
families and in the two single adRP cases with markers
flanking the PRKCG gene reveals a founder effect, with
disease-gene carriers of each pedigree sharing the same
haplotype over an interval 15 cM, including the entire
RP11 region (this haplotype would be expected to have
a frequency of 105, on the basis of allele frequencies in
the U.K. population; see fig. 3). This could imply that
the mutation on the ancestral chromosome took place
relatively recently, although no genealogical link exists
between these families during the past 160 years.
Close genetic association between the RP11 pheno-
type in these families and the Arg659Ser mutation is
clearly evident. In conjunction with the involvement of
an eye-PKC gene in retinal degeneration in Drosophila
(Smith et al. 1991), this suggests that this mutation could
be a cause of RP in these families. As stated above, one
form of PKC is known to phosphorylate rhodopsin, per-
haps as part of an adaptation mechanism. If the enzyme
involved were PRKCG, a mutation in this gene might
be expected to have an effect on photoreceptors’ ad-
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Figure 2 Comparison of sequencing data from (a) a normal and
(b) a heterozygous mutant PRKCG exon 18 sequence. A CrA trans-
version (underlined bases) changes codon 659 from arginine (CGC)
to serine (AGC).
Figure 3 Pedigrees of (a) RP1907 and (b) ADRP24. (On the
basis of the characteristic bimodal expressivity phenotype, this family
was thought to be an RP11 family, but it gave a nonsignificant LOD
score [0.6 at recombination fraction 0] with 19q markers.) Blackened
symbols denote affected individuals; unblackened symbols denote nor-
mal individuals; and gray-shaded symbols denote asymptomatic dis-
ease-gene carriers, on the basis of haplotype analysis. The linked hap-
lotype for 19q markers, including the PRKCG mutation, are shown
below the pedigrees. Allele 1 for PRKCG represents the CrAmutation
at codon 659, whereas allele 2 represents the normal sequence. Re-
striction digests of exon 18 PCR products, which demonstrate absence
of the AciI site in mutated alleles, are also shown, with fragment sizes
of 110 bp (for the mutated allele), 81 bp (for the normal allele), and
49 bp.
aptation or recovery in response to light flashes or to
high or low light levels. Mutations in rhodopsin kinase
and arrestin, both similarly involved in the restoration
of resting potential in photoreceptors after light stimu-
lus, have been shown to cause a rare recessive form of
congenital stationary night blindness (CSNB), known as
“Oguchi disease” (Fuchs et al. 1995; Yamamoto et al.
1997). As in the case of Oguchi disease, onemight expect
a mutation in PKCg, an enzyme, to cause a recessive
rather than a dominant phenotype. However, a mutation
that affects the ability of the photoreceptor to restore
rhodopsin sufficiently to an inactive state might lead to
a background level of constitutive activation, which has
been hypothesized, for several rhodopsin mutations, as
being the cause of a dominant form of CSNB (Rao et
al. 1994). Furthermore, a mutation in the b-subunit of
phosphodiesterase (PDEb), an enzyme, was also found
to cause a dominant form of CSNB (Gal et al. 1994).
Mice deficient in PKCg have been created by use gene-
knockout technology. These animals exhibit mild deficits
in spatial and contextual learning, but no mention is
made, in the published description, of defective vision
(Abeliovich et al. 1993; Chen et al. 1995). If PRKCG
is the RP11 gene in these families, then it could be argued
that these mice are not a true model for a human
PRKCG missense mutation—in which the presence of
the abnormal protein is likely to cause the disease, rather
than the absence of normal enzyme activity. Alterna-
tively, given the incomplete penetrance of the RP11 phe-
notype in some patients, this may be the result of a
genetic background that protects against retinal degen-
eration in the mouse inbred strain.
Nevertheless, the entire PRKCG gene has been se-
quenced in three other families with RP11 linkage, and
no disease-causing mutation has been found. Southern
blots digested with various restriction enzymes and hy-
bridized with a PRKCG cDNA probe also failed to dis-
close any rearrangements in these families. It is possible
that, in these families, another, probably common, dis-
ease-causing mutation could have been missed or could
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lie in either upstream or downstream promoter/regula-
tory regions or introns that have not yet been fully char-
acterized. A search for other RP patients carrying the
Arg659Ser or other mutations in the PRKCG gene, in
other laboratories involved in RP research, would fur-
ther substantiate the involvement of this gene in this
common form of dominant RP. Alternatively, the ab-
sence of causative mutations in a proportion of RP11
families might imply microheterogeneity, a hypothesis
proposed to explain the apparent lack of mutations in
RPGR in 150% of families with RP3 linkage (Fujita et
al. 1997). Nevertheless, it also remains possible that the
Arg659Ser is a rare allelic variant of the PRKCG normal
sequence and is in linkage disequilibrium with the dis-
ease allele in these families. A search for other RP pa-
tients carrying this change may reveal a wider founder
effect, which could further refine the locus for this com-
mon form of dominant RP.
Finally, a number of apparently non–disease-causing
PRKCG polymorphisms were also detected by this
study. One particularly interesting change in exon 18
(TTT647TTC) was found to segregate perfectly with the
disease phenotype in another RP11-linked family (data
not shown). Despite the fact that this change was absent
from the 500 normal control chromosomes, it does not
alter the amino acid sequence. Other neutral nucleotide-
sequence changes (AAT189AAC and GGC411GGT),
non–disease-causing amino acid changes (R141C,
H415Q, and A523D), and a T-nucleotide insertion in
intron 16, 39 bp downstream of exon 16, were also
found. None of these changes were found to segregate
with the disease phenotype in the families in which they
were found, and each was also present in normal
individuals.
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